UNSPSC 85471108: Drainage of basal ganglia with drainage device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to drainage of basal ganglia with drainage device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 009830Z

UNSPSC 85471108 Drainage of basal ganglia with drainage device, percutaneous approach is a Commodity code that shows no relevant recent state and local procurement activity. The six opportunities in the most-recent block include independent medical evaluations for public safety disability pension determinations (City of Phoenix), surgical benefit carve-out management for municipal employees (City of Long Beach), occupational medical surveillance for ferry workers (Washington State Department of Transportation), emergency and specialty hospital services for detained youth (Harris County Juvenile Probation Department), pharmacy benefit management for county employees (Collier County), and temporary health professional staffing across ancillary clinical categories (Santa Clara County Health System). None of these solicitations involve neurological drainage procedures, implantable devices, or percutaneous neurosurgical interventions. The code appears to be tagged to a healthcare procurement taxonomy that state and local governments use for benefits administration, staffing, and clinical services contracting rather than surgical procedures or implantable medical devices themselves.

State and local procurement under this code does not match its nominal scope. Practitioners evaluating opportunities tagged to this UNSPSC should verify the actual goods or services being solicited before investing in pursuit, as the code designation may reflect administrative classification rather than clinical or surgical content. The recent activity reflects benefits and staffing procurement across multiple jurisdictions (Arizona, California, Washington, Florida, Texas) rather than surgical implant or device acquisition.